Header for print stylesheet
You are here:  
DSM Pharmaceuticals Inc. Announces Expanded Service Offering for Solid Dose Formulation Development and CTM Manufacturing
Parsippany,USA,06-Nov-2007

DSM Pharmaceuticals Inc., a leading global supplier of pharmaceutical manufacturing services, announces today that they have expanded their service offerings to include Formulation Development and Clinical Trial Manufacturing for solid dosage form products.

Averaging over 20 product launches per year, DSM has a 37 year history of successfully manufacturing complex solid dosage forms for the commercial pharmaceutical market. “This expansion of services will have significant value-added benefits to our customers in terms of reducing cost and accelerating time to market as they will be able to avoid the high cost of tech transfers required for commercial launch by conducting development, CTM and commercial manufacturing all at DSM’s Greenville, NC facilities,” said Terry Novak, President and Business Unit Director of DSM Pharmaceuticals, Inc.

DSM Pharmaceutical Development Services will include: 

Preformulation
Analytical Development
Stability studies
Formulation Development
 - NCE formulation development
 - Reformulations for line extensions
 - Controlled and Modified release
 - Controlled Substances
Clinical Trial Supply – Phase I-III
Regulatory Support

About DSM Pharmacueticals Inc.
DSM Pharmaceuticals, Inc. a business unit of DSM Pharmaceutical Products, is a global provider of custom manufacturing services to the pharmaceutical and biopharmaceutical industries. Our breadth of manufacturing services include the areas of steriles, orals and topicals, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, and lyophilization services.

About DSM Pharmaceutical Products
DSM Pharmaceutical Products is a global provider of high quality custom contract manufacturing services to the pharmaceutical and biopharmaceutical industries. DSM Pharmaceutical Products provides contract manufacturing services including: advanced intermediates, active ingredients (API's), amino acids and derivatives, mammalian cell culture production (fed-batch and perfusion) of monoclonal antibodies, proteins, vaccines, finished dose manufacturing of solid dose, scheduled drugs, liquids, aseptic liquid and lyophilized products.
From clinical to commercial services, DSM focuses the right resources on providing the highest level of service and quality while applying innovative solutions to satisfy customers’ unique manufacturing needs.

PDF Version (27.5Kb)

Pdf document
For more information
DSM Pharmaceutical Products
+1-973-257-8471
Terry.Novak@dsm.com
footer for print stylesheet